Showing results (131-140 of 299) with videos related to
Sort By:
Pageof 30
AIDS (London, England)|September 26, 2014
Relationship of HIV reservoir characteristics with immune status and viral rebound kinetics in an HIV therapeutic vaccine studyJonathan Z Li, Andrea Heisey, Hayat Ahmed, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|December 17, 2014
Rosuvastatin reduces vascular inflammation and T-cell and monocyte activation in HIV-infected subjects on antiretroviral therapyNicholas T Funderburg, Ying Jiang, Sara M Debanne, et al.AIDS (London, England)|September 20, 2013
Older HIV-infected patients on antiretroviral therapy have B-cell expansion and attenuated CD4 cell increases with immune activation reductionRobert C Kalayjian, John Spritzler, Roy M Matining, et al.The Journal of Infectious Diseases|May 8, 2010
Pretreatment levels of soluble cellular receptors and interleukin-6 are associated with HIV disease progression in subjects treated with highly active antiretroviral therapyRobert C Kalayjian, Rhoderick N Machekano, Nesrine Rizk, et al.The Journal of Infectious Diseases|April 1, 2009
Topically applied recombinant chemokine analogues fully protect macaques from vaginal simian-human immunodeficiency virus challengeRonald S Veazey, Binhua Ling, Linda C Green, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 6, 2015
Valacyclovir Decreases Plasma HIV-1 RNA in HSV-2 Seronegative Individuals: A Randomized Placebo-Controlled Crossover TrialChristophe Vanpouille, Andrea Lisco, Jean-Charles Grivel, et al.AIDS (London, England)|April 20, 2004
Proliferation responses to HIVp24 during antiretroviral therapy do not reflect improved immune phenotype or functionChristoph G Lange, Zhan Xu, Bruce K Patterson, et al.Plos Computational Biology|May 24, 2014
Quantifying and predicting the effect of exogenous interleukin-7 on CD4+ T cells in HIV-1 infectionRodolphe Thiébaut, Julia Drylewicz, Mélanie Prague, et al.The Journal of Infectious Diseases|February 18, 2005
Severe hepatotoxicity associated with nevirapine use in HIV-infected subjectsIan Sanne, Herve Mommeja-Marin, John Hinkle, et al.Plos Pathogens|March 15, 2014
Oral mycobiome analysis of HIV-infected patients: identification of Pichia as an antagonist of opportunistic fungiPranab K Mukherjee, Jyotsna Chandra, Mauricio Retuerto, et al.Pageof 30